Report Detail

Pharma & Healthcare Global Cancer Drugs Market Professional Survey Report 2019

  • RnM3744152
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Cancer Drugs Market Professional Survey Report 2019

Table of Contents

    Executive Summary

      1 Industry Overview of Cancer Drugs

      • 1.1 Definition of Cancer Drugs
      • 1.2 Cancer Drugs Segment by Type
        • 1.2.1 Global Cancer Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Breast Cancer
        • 1.2.3 Blood Cancer
        • 1.2.4 Gastrointestinal Cancer
        • 1.2.5 Prostate Cancer
        • 1.2.6 Skin Cancer
        • 1.2.7 Lung Cancer
        • 1.2.8 Others
      • 1.3 Cancer Drugs Segment by Applications
        • 1.3.1 Global Cancer Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Immunotherapy
        • 1.3.3 Targeted Therapy
        • 1.3.4 Chemotherapy
        • 1.3.5 Hormone Therapy
        • 1.3.6 Others
      • 1.4 Global Cancer Drugs Overall Market
        • 1.4.1 Global Cancer Drugs Revenue (2014-2025)
        • 1.4.2 Global Cancer Drugs Production (2014-2025)
        • 1.4.3 North America Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cancer Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Cancer Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cancer Drugs
      • 2.3 Manufacturing Process Analysis of Cancer Drugs
      • 2.4 Industry Chain Structure of Cancer Drugs

      3 Development and Manufacturing Plants Analysis of Cancer Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cancer Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cancer Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cancer Drugs Production and Capacity Analysis
      • 4.2 Cancer Drugs Revenue Analysis
      • 4.3 Cancer Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Cancer Drugs Regional Market Analysis

      • 5.1 Cancer Drugs Production by Regions
        • 5.1.1 Global Cancer Drugs Production by Regions
        • 5.1.2 Global Cancer Drugs Revenue by Regions
      • 5.2 Cancer Drugs Consumption by Regions
      • 5.3 North America Cancer Drugs Market Analysis
        • 5.3.1 North America Cancer Drugs Production
        • 5.3.2 North America Cancer Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cancer Drugs Import and Export
      • 5.4 Europe Cancer Drugs Market Analysis
        • 5.4.1 Europe Cancer Drugs Production
        • 5.4.2 Europe Cancer Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cancer Drugs Import and Export
      • 5.5 China Cancer Drugs Market Analysis
        • 5.5.1 China Cancer Drugs Production
        • 5.5.2 China Cancer Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cancer Drugs Import and Export
      • 5.6 Japan Cancer Drugs Market Analysis
        • 5.6.1 Japan Cancer Drugs Production
        • 5.6.2 Japan Cancer Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cancer Drugs Import and Export
      • 5.7 Southeast Asia Cancer Drugs Market Analysis
        • 5.7.1 Southeast Asia Cancer Drugs Production
        • 5.7.2 Southeast Asia Cancer Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cancer Drugs Import and Export
      • 5.8 India Cancer Drugs Market Analysis
        • 5.8.1 India Cancer Drugs Production
        • 5.8.2 India Cancer Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cancer Drugs Import and Export

      6 Cancer Drugs Segment Market Analysis (by Type)

      • 6.1 Global Cancer Drugs Production by Type
      • 6.2 Global Cancer Drugs Revenue by Type
      • 6.3 Cancer Drugs Price by Type

      7 Cancer Drugs Segment Market Analysis (by Application)

      • 7.1 Global Cancer Drugs Consumption by Application
      • 7.2 Global Cancer Drugs Consumption Market Share by Application (2014-2019)

      8 Cancer Drugs Major Manufacturers Analysis

      • 8.1 Bayer
        • 8.1.1 Bayer Cancer Drugs Production Sites and Area Served
        • 8.1.2 Bayer Product Introduction, Application and Specification
        • 8.1.3 Bayer Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GlaxoSmithKline
        • 8.2.1 GlaxoSmithKline Cancer Drugs Production Sites and Area Served
        • 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.2.3 GlaxoSmithKline Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Novartis
        • 8.3.1 Novartis Cancer Drugs Production Sites and Area Served
        • 8.3.2 Novartis Product Introduction, Application and Specification
        • 8.3.3 Novartis Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Sanofi and Pfizer
        • 8.4.1 Sanofi and Pfizer Cancer Drugs Production Sites and Area Served
        • 8.4.2 Sanofi and Pfizer Product Introduction, Application and Specification
        • 8.4.3 Sanofi and Pfizer Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Amgen
        • 8.5.1 Amgen Cancer Drugs Production Sites and Area Served
        • 8.5.2 Amgen Product Introduction, Application and Specification
        • 8.5.3 Amgen Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Merck
        • 8.6.1 Merck Cancer Drugs Production Sites and Area Served
        • 8.6.2 Merck Product Introduction, Application and Specification
        • 8.6.3 Merck Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Bristol-Myers Squibb
        • 8.7.1 Bristol-Myers Squibb Cancer Drugs Production Sites and Area Served
        • 8.7.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.7.3 Bristol-Myers Squibb Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Celgene Corporation
        • 8.8.1 Celgene Corporation Cancer Drugs Production Sites and Area Served
        • 8.8.2 Celgene Corporation Product Introduction, Application and Specification
        • 8.8.3 Celgene Corporation Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Ariad Pharmaceuticals
        • 8.9.1 Ariad Pharmaceuticals Cancer Drugs Production Sites and Area Served
        • 8.9.2 Ariad Pharmaceuticals Product Introduction, Application and Specification
        • 8.9.3 Ariad Pharmaceuticals Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Eli Lilly
        • 8.10.1 Eli Lilly Cancer Drugs Production Sites and Area Served
        • 8.10.2 Eli Lilly Product Introduction, Application and Specification
        • 8.10.3 Eli Lilly Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Hoffmann-La Roche
      • 8.12 Boehringer Ingelheim
      • 8.13 Johnson and Johnson
      • 8.14 Teva Pharmaceuticals

      9 Development Trend of Analysis of Cancer Drugs Market

      • 9.1 Global Cancer Drugs Market Trend Analysis
        • 9.1.1 Global Cancer Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cancer Drugs Regional Market Trend
        • 9.2.1 North America Cancer Drugs Forecast 2019-2025
        • 9.2.2 Europe Cancer Drugs Forecast 2019-2025
        • 9.2.3 China Cancer Drugs Forecast 2019-2025
        • 9.2.4 Japan Cancer Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Cancer Drugs Forecast 2019-2025
        • 9.2.6 India Cancer Drugs Forecast 2019-2025
      • 9.3 Cancer Drugs Market Trend (Product Type)
      • 9.4 Cancer Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cancer Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        It is used in the treatment of cancer.

        The global Cancer Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Drugs market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Drugs in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Cancer Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Bayer
        GlaxoSmithKline
        Novartis
        Sanofi and Pfizer
        Amgen
        Merck
        Bristol-Myers Squibb
        Celgene Corporation
        Ariad Pharmaceuticals
        Eli Lilly
        Hoffmann-La Roche
        Boehringer Ingelheim
        Johnson and Johnson
        Teva Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Breast Cancer
        Blood Cancer
        Gastrointestinal Cancer
        Prostate Cancer
        Skin Cancer
        Lung Cancer
        Others

        Segment by Application
        Immunotherapy
        Targeted Therapy
        Chemotherapy
        Hormone Therapy
        Others


        Summary:
        Get latest Market Research Reports on Cancer Drugs. Industry analysis & Market Report on Cancer Drugs is a syndicated market report, published as Global Cancer Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,808.33
        4,212.49
        5,616.65
        3,170.29
        4,755.44
        6,340.59
        378,773.50
        568,160.25
        757,547.00
        249,466.00
        374,199.00
        498,932.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report